Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
ASCO 2020 - Lung Cancer
ASCO 2020 - Lung Cancer
ASCO 2020 Lung Cancer Highlights
Read More
ASCO 2020 - Lung Cancer
Impact of Immune-Related Adverse Events on Checkpoint Inhibitor Consolidation Therapy in Stage III NSCLC
Read More
ASCO 2020 - Lung Cancer
Characteristics of Patients Who Achieve Long-Term Response with PD-1 Blockade
Read More
ASCO 2020 - Lung Cancer
Smoking Cessation and Lung Cancer: Recent Quitters Benefit Too
Read More
ASCO 2020 - Lung Cancer
Weekly Epirubicin as Second-Line Therapy for Malignant Pleural Mesothelioma
Read More
ASCO 2020 - Lung Cancer
Patterns of Acquired Resistance in Patients with NSCLC Who Receive PD-1 Inhibitors
Read More
ASCO 2020 - Lung Cancer
ADAURA Results: Osimertinib as Adjuvant Therapy for EGFR-Mutated NSCLC
Read More
ASCO 2020 - Lung Cancer
Cediranib Combined with Olaparib Is Active in Patients with Platinum-Pretreated SCLC
Read More
ASCO 2020 - Lung Cancer
Nationwide Genomic Screening Network Can Be Effective in Identifying Rare Targetable Genetic Alterations
Read More
ASCO 2020 - Lung Cancer
Combination of Nivolumab, Ipilimumab, and Chemotherapy in Metastatic NSCLC
Read More
1
2
Page 1 of 2
Results 1 - 10 of 16